Tango Therapeutics Inc.近期向美国证券交易委员会(SEC)提交了一份文件。这份文件明确显示,Barbara Weber 担任公司执行主席一职的雇佣关系,已于2026年8月3日正式终止。这一人事变动,已被正式记录并对外公开。
Tango Therapeutics Inc.近期向美国证券交易委员会(SEC)提交了一份文件。这份文件明确显示,Barbara Weber 担任公司执行主席一职的雇佣关系,已于2026年8月3日正式终止。这一人事变动,已被正式记录并对外公开。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.